US Acute Myeloid Leukemia Market Advances with Targeted Therapy Innovation
The United States holds the largest share of the Acute Myeloid Leukemia Market, supported by its advanced oncology infrastructure, strong pharmaceutical research ecosystem, and widespread adoption of innovative leukemia therapies. The country benefits from substantial investments in cancer research, increasing … Read more